Hologic granted FDA Emergency Use Authorization for asymptomatic COVID-19 testing with Panther Fusion SARS-CoV-2 assay
On Sept. 28, 2020, Hologic announced that its Panther Fusion SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
On Sept. 28, 2020, Hologic announced that its Panther Fusion SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
On Sept. 28, 2020, INOVIO announced that the U.S. Food and Drug Administration (FDA) has notified the company…
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…
On Sept. 23, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Sept. 22, 2020, the U.S. Food and Drug Administration (FDA) the launch of the Digital Health Center…
On Sept. 18, 2020, Roche announced the launch of its Elecsys Anti-SARS-CoV-2 S antibody test for markets accepting…
On Sept. 17, 2020, Todos Medical announced that NLC Pharma had added the dietary supplement NLC-001 to its…
On Sept. 16, 2020, AXIM Biotechnologies announced that it had filed an Emergency Use Authorization (EUA) application with…
On Sept. 15, 2020, the U.S. Food and Drug Administration (FDA) awarded a $5.4 million research contract to…
On Sept. 14, 2020, Vaxart announced that the U.S. Food and Drug Administration (FDA) has completed its review…
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 11, 2020, Todos Medical announced that the U.S. Food and Drug Administration (FDA) has added the…
On Sept. 9, 2020, Pfizer and BioNTech announced that they had concluded exploratory talks with the European Commission…
On Sept. 9, 2020, GlaxoSmithKline and Innoviva announced the U.S. Food and Drug Administration (FDA) had approved a…
On Sept. 8, 2020, INOVIO announced that Thermo Fisher Scientific, the world leader in serving science, had signed…
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ᄋRNA (OR-100) collection device was included along with other…
On Sept. 3, 2020, Roche announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the…
On Sept. 1, 2020, Roche announced FDA approval for the cobas HIV-1/HIV-2 Qualitative Test for use on the…
On Aug. 31, 2020, T2 Biosystems announced that it received FDA emergency use authorization (EUA) for its COVID-19…
On Aug. 28, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) expanded the Emergency Use…
On Aug. 28, 2020, the U.S. Department of Veterans Affairs (VA) announced a new clinical trial to study…
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
On Aug. 26, 2020, Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use…
On Aug. 24, 2020, XBiotech announced that the U.S. Food and Drug Administration (FDA) issued an emergency use…
On Aug. 23, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
On Aug. 17, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Enspryng (satralizumab-mwge) for the treatment…
On Aug. 15, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to…
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
On Aug. 12, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to NS Pharma’s Viltepso…